US Stock MarketDetailed Quotes
MGX Metagenomi Technologies, LLC
- 6.580
- -0.590-8.23%
Trading May 23 15:16 ET
246.51MMarket Cap-3191P/E (TTM)
8.175High6.510Low30.33KVolume7.300Open7.170Pre Close211.51KTurnover0.49%Turnover RatioLossP/E (Static)37.46MShares12.74052wk High0.89P/B41.13MFloat Cap5.50052wk Low--Dividend TTM6.25MShs Float12.740Historical High--Div YieldTTM23.22%Amplitude5.500Historical Low6.974Avg Price1Lot Size
About Metagenomi Technologies, LLC Company
Metagenomi, Inc. is a precision genetic medicines company, which engages in the business of developing next generation gene-editing technologies and therapies. Its business activities include developing gene edit-ing toolbox, ther-a-peu-tic focus, and processing discovery platform. The company was founded by Brian C. Thomas on September 16, 2016 and is headquartered in Emeryville, CA.
Company Profile
SymbolMGX
Company NameMetagenomi Technologies, LLC
Listing DateFeb 9, 2024
Issue Price15.00
Founded2016
CEOMr. Brian C. Thomas, PhD
MarketNASDAQ
Employees236
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address5959 Horton Street,7th floor
CityEmeryville
ProvinceCalifornia
CountryUnited States of America
Zip Code94608
Phone1-510-871-4880
Websitehttp://www.metagenomi.co
Company Executives
- Name
- Position
- Salary
- Brian C. Thomas, PhD
- Chief Executive Officer and Chairman of the Board
- 7.52M
- Dr. Sarah B. Noonberg, M.D.,PhD
- Chief Medical Officer
- 2.04M
- Dr. Luis G. Borges, PhD
- Chief Scientific Officer
- --
- Pamela Wapnick, M.B.A.
- Chief Financial Officer and Chief Accounting Officer
- --
- Simon Harnest, M. Sc.
- Chief Investment Officer and Senior Vice President of Strategy
- --
- Dr. Jian Irish, M.B.A.,PhD
- President, Chief Operating Officer and Director
- 2.27M
- Michael Conway, C.P.A.,M.B.A.
- Vice President of Finance
- --
- Matthew L. Wein, J.D.
- Vice President, Corporate Legal and Compliance and Corporate Secretary
- --
- Alan Brooks, PhD
- Senior Vice President of Preclinical
- --
- Christopher T. Brown, PhD
- Vice President of Discovery
- --
- Dr. Simren Delaney, L.L.M.,PhD
- Vice President, Intellectual Property and Legal Operations
- --
- Dr. Willard H. Dere, M.D.
- Independent Director
- 49.20K
- Sebastian Bernales, PhD
- Independent Director
- --
- Dr. Juergen Eckhardt, M.B.A.,M.D.
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
